Publications by authors named "Angela Oostlander"

Claim this Profile
B
Bone loss in patients with inflammatory bowel disease: cause, detection and treatment.
Nathalie Bravenboer, Angela E Oostlander, Adriaan A van Bodegraven

Curr Opin Gastroenterol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncology drugs in the crosshairs of pharmaceutical crime.
Bastiaan J Venhuis, Angela E Oostlander, Domenico Di Giorgio, Ruth Mosimann, Ines du Plessis

Lancet Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peri-prosthetic tissue cells show osteogenic capacity to differentiate into the osteoblastic lineage.
Monique A E Schoeman, Angela E Oostlander, Karien Ede Rooij, Edward R Valstar, Rob G H H Nelissen

J Orthop Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural and mechanical characterisation of the peri-prosthetic tissue surrounding loosened hip prostheses. An explorative study.
Astrid Moerman, Amir A Zadpoor, Angela Oostlander, Monique Schoeman, Parisa Rahnamay Moshtagh

J Mech Behav Biomed Mater· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innate immune response and implant loosening: Interferon gamma is inversely associated with early migration of total knee prostheses.
Monique A E Schoeman, Bart G Pijls, Angela E Oostlander, Johan C Keurentjes, Edward R Valstar

J Orthop Res· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of GSK3β Stimulates BMP Signaling and Decreases SOST Expression Which Results in Enhanced Osteoblast Differentiation.
Monique A E Schoeman, Martiene J C Moester, Angela E Oostlander, Eric L Kaijzel, Edward R Valstar

J Cell Biochem· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation.
Ad A van Bodegraven, Nathalie Bravenboer, Birgit I Witte, Gerard Dijkstra, C Janneke van der Woude, Angela E Oostlander

Gut· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone cells from patients with quiescent Crohn's disease show a reduced growth potential and an impeded maturation.
Angela E Oostlander, Nathalie Bravenboer, Huib W van Essen, Jenneke Klein-Nulend, Willem F Lems

J Cell Biochem· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell-mediated increased osteoclast formation from peripheral blood as a mechanism for Crohn's disease-associated bone loss.
Angela E Oostlander, Vincent Everts, Ton Schoenmaker, Nathalie Bravenboer, Sandra J van Vliet

J Cell Biochem· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histomorphometric analysis reveals reduced bone mass and bone formation in patients with quiescent Crohn's disease.
Angela E Oostlander, Nathalie Bravenboer, Evelien Sohl, Paulien J Holzmann, Christien J van der Woude

Gastroenterology· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapamycin modulates the eNOS vs. shear stress relationship.
Caroline Cheng, Dennie Tempel, Angela Oostlander, Frank Helderman, Frank Gijsen

Cardiovasc Res· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis